Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomia

International Journal of Molecular Medicine

Volumn 35, Issue 1, 2015, Pages 81-91

  Ge, Qinyu ^a   Zhu, Yanan ^a   Li, Hailing ^b   Tian, Fei ^a   Xie, Xueying ^a   Bai, Yunfei ^b  

^a Southeast University   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Abnormal pregnancy; Circulating microRNAs; Fetal macrosomia; Low density array

Indexed keywords

MICRORNA; MICRORNA 125A 3P; MICRORNA 130B 3P; MICRORNA 138 5P; MICRORNA 141 3P; MICRORNA 1413P; MICRORNA 143 3P; MICRORNA 149 5P; MICRORNA 16 5P; MICRORNA 181A; MICRORNA 18A 5P; MICRORNA 200C; MICRORNA 200C 3P; MICRORNA 208A; MICRORNA 208B; MICRORNA 221; MICRORNA 299 3P; MICRORNA 29B 3P; MICRORNA 30A 3P; MICRORNA 331 5P; MICRORNA 34A 5P; MICRORNA 381; MICRORNA 451A; MICRORNA 523 3P; MICRORNA 576 3P; MICRORNA 661; MICRORNA 7 5P; MICRORNA 708 5P; MICRORNA 9 5P; MICRORNA499A 5P; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MACROSOMIA; MATERNAL PLASMA; PREGNANCY DISORDER; PREGNANT WOMAN; PRENATAL DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TAQMAN LOW-DENSITY ARRAY; UPREGULATION; VALIDATION STUDY; WEIGHT GAIN; BLOOD; CASE CONTROL STUDY; CLUSTER ANALYSIS; FETAL MACROSOMIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; PREGNANCY; RISK FACTOR; YOUNG ADULT;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; FETAL MACROSOMIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84917691108     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1989     Document Type: Article

References (42)

1. Boulet SL, Alexander GR, Salihu HM and Pass M: Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 188: 1372-1378, 2003.
2. Henriksen T: The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 87: 134-145, 2008.
3. Schwartz R and Teramo KA: What is the significance of macrosomia? Diabetes Care 22: 1201-1205, 1999.
4. Haram K, Pirhonen J and Bergsjø P: Suspected big baby: a difficult clinical problem in obstetrics. Acta Obstet Gynecol Scand 81: 185-194, 2002.
5. Ehrenberg HM, Mercer BM and Catalano PM: The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 191: 964-968, 2004.
6. Jang HC, Cho NH, Min YK, Han IK, Jung KB and Metzger BE: Increased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in Korean women with GDM. Diabetes Care 20: 1582-1588, 1997.
7. Yu Z, Sun JQ, Haas JD, Gu Y, Li Z and Lin X: Macrosomia is associated with high weight-for-height in children aged 1-3 years in Shanghai, China. Int J Obes (Lond) 32: 55-60, 2008.
8. Segregur J, Buković D, Milinović D, et al: Fetal macrosomia in pregnant women with gestational diabetes. Coll Antropol 33: 1121-1127, 2009.
9. Suhonen L, Hiilesmaa V, Kaaja R and Teramo K: Detection of pregnancies with high risk of fetal macrosomia among women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 87: 940-945, 2008.
10. Vohr BR and Boney CM: Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 21: 149-157, 2008.
11. Ornoy A: Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol 32: 205-212, 2011.
12. Van Assche FA, Holemans K and Aerts L: Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull 60: 173-182, 2001.
13. Kim YS, Yoon YJ, Jatoi I and Kim Y: Fetal macrosomia in experimental maternal diabetes. Am J Obstet Gynecol 139: 27-32, 1981.
14. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
15. Mattick JS and Makunin IV: Non-coding RNA. Hum Mol Genet 15 Spec No 1: R17-R29, 2006.
16. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
17. Reid G, Kirschner MB and van Zandwijk N: Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 80: 193-208, 2011.
18. Tan KS, Armugam A, Sepramaniam S, et al: Expression profile of microRNAs in young stroke patients. PLoS One 4: e7689, 2009.
19. Zampetaki A, Willeit P, Drozdov I, Kiechl S and Mayr M: Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 93: 555-562, 2012.
20. Wang G, Tam LS, Li EK, et al: Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20: 493-500, 2011.
21. Corsten MF, Dennert R, Jochems S, et al: Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3: 499-506, 2010.
22. Ng EK, Tsang WP, Ng SS, et al: MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706, 2009.
23. Huang Z, Huang D, Ni S, Peng Z, Sheng W and Du X: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126, 2010.
24. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
25. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW and Lo YM: mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 100: 4748-4753, 2003.
26. Fanson BG, Osmack P and Di Bisceglie AM: A comparison between the phenol-chloroform method of RNA extraction and the QIAamp viral RNA kit in the extraction of hepatitis C and GB virus-C/hepatitis G viral RNA from serum. J Virol Methods 89: 23-27, 2000.
27. Liu J, Leng J, Tang C, Liu G, Hay J, Wang J, Wen S, Li Z and She Y: Maternal glucose level and body mass index measured at gestational diabetes mellitus screening and the risk of macrosomia: results from a perinatal cohort study. BMJ Open 4: e004538, 2014.
28. Prats-Puig A, Ortega FJ, Mercader JM, et al: Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab 98: E1655-E1660, 2013.
29. Ortega FJ, Mercader JM, Catalán V, et al: Targeting the circulating microRNA signature of obesity. Clin Chem 59: 781-792, 2013.
30. Jordan SD, Krüger M, Willmes DM, et al: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13: 434-446, 2011.
31. Fu T, Choi SE, Kim DH, et al: Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho. Proc Natl Acad Sci USA 109: 16137-16142, 2012.
32. Yang Q, Lu J, Wang S, Li H, Ge Q and Lu Z: Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta 412: 2167-2173, 2011.
33. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ and Miller N: Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76, 2008.
34. Xie T, Liang J, Guo R, Liu N, Noble PW and Jiang D: Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 43: 479-487, 2011.
35. Cortez MA, Welsh JW and Calin GA: Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res 195: 151-161, 2012.
36. Bianchi F, Nicassio F, Marzi M, et al: A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 3: 495-503, 2011.
37. Chen X, Hu Z, Wang W, et al: Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 130: 1620-1628, 2012.
38. Zhang Y, Zhang R and Su B: Diversity and evolution of microRNA gene clusters. Sci China C Life Sci 52: 261-266, 2009.
39. Kim VN and Nam JW: Genomics of microRNA. Trends Genet 22: 165-173, 2006.
40. Xu J and Wong C: A computational screen for mouse signaling pathways targeted by microRNA clusters. RNA 14: 1276-1283, 2008.
41. Baskerville S and Bartel DP: Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11: 241-247, 2005.
42. Hsu SD, Lin FM, Wu WY, et al: miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-D169, 2011.